{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:47:08Z","timestamp":1782251228033,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thekneejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Knee"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.knee.2026.104443","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T18:43:48Z","timestamp":1777142628000},"page":"104443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Intraosseous vancomycin results in lower superficial and deep infection rate compared with alternative intravenous methods in total knee arthroplasty: a time-stratified meta-analysis"],"prefix":"10.1016","volume":"61","author":[{"given":"Fardis","family":"Vosoughi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diako","family":"Seyedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parnian","family":"Rahnama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5987-9873","authenticated-orcid":false,"given":"Farhad","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Imani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman Menbari","family":"Oskouie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.knee.2026.104443_b0005","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.arth.2025.05.124","article-title":"Trends in Medicare arthroplasty procedure volume: projecting from 2025 to 2040","volume":"40","author":"Jones","year":"2025","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2026.104443_b0010","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1016\/j.arth.2020.06.046","article-title":"How are we measuring cost-effectiveness in total joint arthroplasty studies? Systematic review of the literature","volume":"35","author":"Lan","year":"2020","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2026.104443_b0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12178-012-9139-6","article-title":"Assessing the value of a total joint replacement","volume":"5","author":"Bumpass","year":"2012","journal-title":"Curr Rev Musculoskelet Med"},{"key":"10.1016\/j.knee.2026.104443_b0020","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1007\/s00402-024-05301-w","article-title":"Preventive strategies to reduce the rate of periprosthetic infections in total joint arthroplasty; a comprehensive review","volume":"144","author":"Egerci","year":"2024","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.knee.2026.104443_b0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11999-009-0945-0","article-title":"The epidemiology of revision total knee arthroplasty in the United States","volume":"468","author":"Bozic","year":"2010","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.knee.2026.104443_b0030","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.arth.2024.01.032","article-title":"Direct hospital costs per case of periprosthetic hip and knee joint infections in Europe \u2013 a systematic review","volume":"39","author":"Szymski","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2026.104443_b0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1055\/s-0033-1364102","article-title":"Organism profile in periprosthetic joint infection: Pathogens differ at two arthroplasty infection referral centers in Europe and in the United States","volume":"27","author":"Aggarwal","year":"2014","journal-title":"J Knee Surg"},{"key":"10.1016\/j.knee.2026.104443_b0040","unstructured":"Ayoade F, Li D, Mabrouk A, Todd J. Periprosthetic joint infection; 2023. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448131\/.[Last accessed November 2025]."},{"key":"10.1016\/j.knee.2026.104443_b0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cmi.2021.06.006","article-title":"Microbiology of hip and knee periprosthetic joint infections: a database study","volume":"28","author":"Tai","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.knee.2026.104443_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2024.07.019","article-title":"Early periprosthetic joint infections in total hip and knee arthroplasty: Microorganisms, mortality, and implant survival using a combined dataset from the Dutch Arthroplasty Register and the Dutch National Nosocomial Surveillance Network","volume":"40","author":"van Veghel","year":"2025","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2026.104443_b0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00264-009-0797-y","article-title":"The microbiology of the infected knee arthroplasty","volume":"34","author":"Nickinson","year":"2010","journal-title":"Int Orthop"},{"key":"10.1016\/j.knee.2026.104443_b0060","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00228-012-1259-9","article-title":"Vancomycin-induced nephrotoxicity: Mechanism, incidence, risk factors and special populations. A literature review","volume":"68","author":"Elyasi","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.knee.2026.104443_b0065","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/infdis\/164.6.1180","article-title":"Red man syndrome: incidence, etiology, and prophylaxis","volume":"164","author":"Wallace","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.knee.2026.104443_b0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1345\/aph.1P583","article-title":"Vancomycin-induced neutropenia: is it dose- or duration-related?","volume":"45","author":"Black","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.knee.2026.104443_b0075","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s11999-017-5302-0","article-title":"Vancomycin prophylaxis for total joint arthroplasty: incorrectly dosed and has a higher rate of periprosthetic infection than cefazolin","volume":"475","author":"Kheir","year":"2017","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.knee.2026.104443_b0080","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s11999-014-4062-3","article-title":"Addition of vancomycin to cefazolin prophylaxis is associated with acute kidney injury after primary joint arthroplasty","volume":"473","author":"Courtney","year":"2015","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.knee.2026.104443_b0085","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.arth.2025.04.074","article-title":"Superior clinical results with intraosseous vancomycin in primary total knee arthroplasty","volume":"40","author":"Park","year":"2025","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2026.104443_b0090","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.arth.2025.04.060","article-title":"The AAHKS best podium presentation research award: intraosseous vancomycin reduces the rate of periprosthetic joint infection following aseptic revision total knee arthroplasty","volume":"40","author":"McNamara","year":"2025","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2026.104443_b0095","doi-asserted-by":"crossref","unstructured":"Park KJ, Chapleau J, Sullivan TC, Clyburn TA, Incavo SJ. 2021 Chitranjan S. Ranawat Award: intraosseous vancomycin reduces periprosthetic joint infection in primary total knee arthroplasty at 90-day follow-up. Bone Joint J 2021;103-B(6 Suppl A):13\u201317.","DOI":"10.1302\/0301-620X.103B6.BJJ-2020-2401.R1"},{"key":"10.1016\/j.knee.2026.104443_b0100","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1007\/s00402-024-05513-0","article-title":"Safety and effectiveness of intraosseous regional prophylactic antibiotics in total knee arthroplasty: a systematic review and meta-analysis","volume":"144","author":"Yu","year":"2024","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.knee.2026.104443_b0105","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.7150\/ijms.47655","article-title":"Successful two-stage exchange arthroplasty for periprosthetic infection following total knee arthroplasty: the impact of timing on eradication of infection","volume":"18","author":"Vielgut","year":"2021","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.knee.2026.104443_b0110","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.40457","article-title":"Incidence, microbiological studies, and factors associated with prosthetic joint infection after total knee arthroplasty","volume":"6","author":"Weinstein","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.knee.2026.104443_b0115","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.knee.2026.104443_b0120","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.arth.2018.03.013","article-title":"The AAHKS Clinical Research Award: intraosseous regional prophylaxis provides higher tissue concentrations in high BMI patients in total knee arthroplasty: a randomized trial","volume":"33","author":"Chin","year":"2018","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2026.104443_b0125","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.artd.2020.02.001","article-title":"Clinical outcome evaluation of intraosseous vancomycin in total knee arthroplasty","volume":"6","author":"Harper","year":"2020","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.knee.2026.104443_b0130","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.arth.2020.12.034","article-title":"Intraosseous regional administration of vancomycin in primary total knee arthroplasty does not increase the risk of vancomycin-associated complications","volume":"36","author":"Klasan","year":"2021","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2026.104443_b0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.35366\/115812","article-title":"Intraosseous vancomycin in total knee arthroplasty","volume":"38","author":"Mart\u00ednez","year":"2024","journal-title":"Acta Ortop Mex"},{"key":"10.1016\/j.knee.2026.104443_b0140","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1097\/CORR.0000000000001919","article-title":"Intraosseous regional prophylactic antibiotics decrease the risk of prosthetic joint infection in primary TKA: a multicenter study","volume":"479","author":"Parkinson","year":"2021","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.knee.2026.104443_b0145","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1016\/j.arth.2024.02.083","article-title":"Intraosseous versus intravenous vancomycin in tourniquetless primary total knee arthroplasty: a randomized trial","volume":"39","author":"Wininger","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2026.104443_b0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11999-013-3038-z","article-title":"The Mark Coventry Award: higher tissue concentrations of vancomycin with low-dose intraosseous regional versus systemic prophylaxis in TKA: a randomized trial","volume":"472","author":"Young","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.knee.2026.104443_b0155","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11999.0000000000000013","article-title":"The John N. Insall Award: Higher tissue concentrations of vancomycin achieved with intraosseous regional prophylaxis in revision TKA: a randomized controlled trial","volume":"476","author":"Young","year":"2018","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.knee.2026.104443_b0160","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.arth.2023.04.028","article-title":"Otto Aufranc Award: intraosseous vancomycin in total hip arthroplasty \u2013 Superior tissue concentrations and improved efficiency","volume":"38","author":"Harper","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2026.104443_b0165","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.arth.2022.01.057","article-title":"Higher tissue concentrations of vancomycin achieved with low-dose intraosseous injection versus intravenous despite limited tourniquet duration in primary total knee arthroplasty: a randomized trial","volume":"37","author":"Spangehl","year":"2022","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2026.104443_b0170","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.knee.2026.104443_b0175","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.knee.2026.104443_b0180","doi-asserted-by":"crossref","first-page":"102553","DOI":"10.1016\/j.jcot.2024.102553","article-title":"Intraosseous regional antibiotic prophylaxis in total joint arthroplasty (TJA): systematic review and meta-analysis","volume":"57","author":"Viswanathan","year":"2024","journal-title":"J Clin Orthop Trauma"},{"key":"10.1016\/j.knee.2026.104443_b0185","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1016\/j.arth.2023.01.043","article-title":"Intraosseous vancomycin may not be helpful in aseptic revision knee arthroplasty: a single-surgeon consecutive case series","volume":"38","author":"Lachiewicz","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2026.104443_b0190","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2106\/00004623-200707000-00027","article-title":"Prevention of perioperative infection","volume":"89","author":"Fletcher","year":"2007","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"10.1016\/j.knee.2026.104443_b0195","article-title":"Prevention of periprosthetic joint infection (PJI): a clinical practice protocol in high-risk patients","volume":"5","author":"Iannotti","year":"2020","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.knee.2026.104443_b0200","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1054\/arth.2003.50053","article-title":"Regional and systemic prophylaxis with teicoplanin in total knee arthroplasty: a tissue penetration study","volume":"18","author":"Lazzarini","year":"2003","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2026.104443_b0205","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1302\/0301-620X.93B4.24969","article-title":"MRSA colonisation and subsequent risk of infection despite effective eradication in orthopaedic elective surgery","volume":"93","author":"Murphy","year":"2011","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.knee.2026.104443_b0210","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1007\/s11999-011-2111-8","article-title":"Are bone and serum cefazolin concentrations adequate for antimicrobial prophylaxis?","volume":"469","author":"Yamada","year":"2011","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.knee.2026.104443_b0215","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.knee.2026.104443_b0220","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0924-8579(98)00025-9","article-title":"Comparative safety of teicoplanin and vancomycin","volume":"10","author":"Wilson","year":"1998","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.knee.2026.104443_b0225","doi-asserted-by":"crossref","first-page":"e6903","DOI":"10.1097\/MD.0000000000006903","article-title":"Timing of preoperative antibiotic prophylaxis in 54,552 patients and the risk of surgical site infection: a systematic review and meta-analysis","volume":"96","author":"De Jonge","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.knee.2026.104443_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2012.01.087","article-title":"When the timing is right: Antibiotic timing and infection after cardiac surgery","volume":"144","author":"Koch","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.knee.2026.104443_b0235","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jac\/dkl279","article-title":"Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections","volume":"58","author":"Garey","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.knee.2026.104443_bib251","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1530\/EOR-22-0130","article-title":"Intraosseous regional prophylactic antibiotics decrease the risk of infection in total knee arthroplasty compared with intravenous antibiotics: a systematic review and meta-analysis","volume":"8","author":"Lei","year":"2023","journal-title":"EFORT Open Rev"},{"key":"10.1016\/j.knee.2026.104443_b0240","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMra2203477","article-title":"Periprosthetic joint infection","volume":"388","author":"Patel","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.knee.2026.104443_b0245","first-page":"649","article-title":"Timing of surgical antibiotic prophylaxis and the risk of surgical site infection","volume":"148","author":"Hawn","year":"2013","journal-title":"J Am Med AssocSurg"},{"key":"10.1016\/j.knee.2026.104443_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.artd.2025.101878","article-title":"Intraosseous vancomycin in total knee arthroplasty: a systematic review and meta-analysis","volume":"36","author":"Puga","year":"2025","journal-title":"Arthroplast Today"}],"container-title":["The Knee"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968016026001225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968016026001225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:54:55Z","timestamp":1782248095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968016026001225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":51,"alternative-id":["S0968016026001225"],"URL":"https:\/\/doi.org\/10.1016\/j.knee.2026.104443","relation":{},"ISSN":["0968-0160"],"issn-type":[{"value":"0968-0160","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraosseous vancomycin results in lower superficial and deep infection rate compared with alternative intravenous methods in total knee arthroplasty: a time-stratified meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Knee","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.knee.2026.104443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104443"}}